BIOMAT Database Logo BIOMAT Database Logo

Dasatinib in relapsed or plateau-phase multiple myeloma. 2009

Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Division of Geriatrics and Nutritional Science, St Louis, MO 63110, USA. twildes@dom.wustl.edu

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069439 Dasatinib A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,BMS 354825,BMS-354825,BMS354825,N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,Sprycel,354825, BMS
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma.
October 2009, American journal of hematology,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Carfilzomib: in relapsed, or relapsed and refractory, multiple myeloma.
October 2012, Drugs,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma.
October 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
October 2007, Clinical cancer research : an official journal of the American Association for Cancer Research,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Frequency of infection in plateau-phase multiple myeloma.
July 1994, Lancet (London, England),
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Teclistamab in Relapsed or Refractory Multiple Myeloma.
November 2022, The New England journal of medicine,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Teclistamab in Relapsed or Refractory Multiple Myeloma.
November 2022, The New England journal of medicine,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Teclistamab in Relapsed or Refractory Multiple Myeloma.
August 2022, The New England journal of medicine,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
March 2018, British journal of haematology,
Tanya M Wildes, and Elizabeth Procknow, and Feng Gao, and John F Dipersio, and Ravi Vij
A phase I study of thymoglobulin for relapsed or refractory multiple myeloma.
February 2016, Leukemia & lymphoma,
Copied contents to your clipboard!